中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

外科理念指导下的大肝癌放疗

方子燕 黎功

引用本文:
Citation:

外科理念指导下的大肝癌放疗

DOI: 10.3969/j.issn.1001-5256.2014.03.005
详细信息
  • 中图分类号: R735.7

Radiotherapy for large hepatocellular carcinoma under the guidance of surgical principle

  • 摘要:

    近年来随着医疗技术水平的提高,肝癌的治疗疗效较前有所提高,但对于大肝癌的治疗仍是临床治疗难点。介绍了大肝癌的生物学特性,对大肝癌的手术治疗(包括肝切除术和肝移植术)、放射治疗的疗效进行了阐述。认为借鉴外科理念,放疗为不能手术的患者提供了一个新的选择。但如何量化肝功能储备的指标,如何限制健肝的体积及受照射剂量,联合其他局部治疗提高肿瘤控制率,仍是亟待解决的问题。

     

  • [1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
    [2]BOSCH FX, RIBES J, DIAZ M, et al.Primary liver cancer:worldwide incidence and trends[J].Gastroenterology, 2004, 127 (5 Suppl 1) :s5-s16.
    [3]CHEN XP.Liver resection experience for the treatment of large hepatocellular carcinoma[J].J Hepatobiliary Surg, 1994 (4) :193-195. (in Chinese) 陈孝平.肝切除治疗巨大肝癌的体会[J].肝胆外科杂志, 1994 (4) :193-195.
    [4]YANG JM, KAN T, CHEN H, et al.The treatment of large liver cancer with lobe resection[J].Chin J Hepatobiliary Surg, 1999, 5 (1) :50-51. (in Chinese) 杨甲梅, 阚彤, 陈汉, 等.肝叶切除治疗特大肝癌[J].中华肝胆外科杂志, 1999, 5 (1) :50-51.
    [5]RUI JA, WANG SB, CHEN SG, et al.The treatment of primary liver cancer with a series of therapy including surgery operation[J].Chin J Oncol, 2001, 23 (5) :69-71. (in Chinese) 芮静安, 王少斌, 陈曙光, 等.以手术为主的系列疗法治疗原发性大肝癌 (附191例报告) [J].中华肿瘤杂志, 2001, 23 (5) :69-71.
    [6]ALVES R, ALVES D, GUZ B, et al.Advanced hepatocellular carcinoma.Review of targeted molecular drugs[J].Ann Hepatol, 2011, 10 (1) :21-27.
    [7]LAU WY, HO SK, YU SC, et al.Salvage surgery following downstaging of unresectable hepatocellular carcinoma[J].Ann Surg, 2004, 240 (2) :299-305.
    [8]WU MC, LI AJ.The comprehensive treatment of large hepatocellular carcinoma should be valued[J].Nat Med J China, 2006, 86 (24) :1657-1659. (in Chinese) 吴孟超, 李爱军.应重视大肝癌的综合治疗[J].中华医学杂志, 2006, 86 (24) :1657-1659.
    [9] BRUIX J, Sherman M.Management of hepatocellular carcinoma[J].Hepatology, 2005, 42 (5) :1208-1236.
    [10]ALBERTS SR, GORES GJ, KIM GP, et al.Treatment options for hepatobiliary and pancreatic cancer[J].Mayo Clin Proc, 2007, 82 (5) :628-637.
    [11]CHEN XP, QIU FZ, WU ZD, et al.Long-term outcome of resection of large hepatocellular carcinoma[J].Br J Surg, 2006, 93 (5) :600-606.
    [12]CHEN XP, WU Z, QIU F.Hepatectomy for huge primary liver cancer:report of 171 patients[J].Chin J Surg, 2000, 38 (1) :6-9.
    [13]ZHOU XD, TANG ZY, MA ZC, et al.Surgery for large primary liver cancer more than 10 cm in diameter[J].J Cancer Res Clin Oncol, 2003, 129 (9) :543-548.
    [14]PANDEY D, LEE KH, WAI CT, et al.Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection[J].Ann Surg Oncol, 2007, 14 (10) :2817-2823.
    [15]PAWLIK TM, POON RT, ABDALLA EK, et al.Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma[J].Arch Surg, 2005, 140 (5) :450-458.
    [16]IKAI I, ARII S, KOJIRO M, et al.Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey[J].Cancer, 2004, 101 (4) :796-802.
    [17]GRAZIADEI IW, SANDMUELLER H, WALDENBERGER P, et al.Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome[J].Liver Transpl, 2003, 9 (6) :557-563.
    [18]KOKUDO N, MAKUUCHI M.Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan:the J-HCC guidelines[J].J Gastroenterol, 2009, 44 (19) :119-121.
    [19]FERRARI FS, STELLA A, PASQUINUCCI P, et al.Treatment of small hepatocellular carcinoma:a comparison of techniques and long-term results[J].Eur J Gastroenterol Hepatol, 2006, 18 (6) :659-672.
    [20]KE CQ, PENG EL.Non-surgical treatment of primary liver cancer[J].China Med Herald, 2013, 10 (4) :32-35. (in Chinese) 柯传庆, 彭思兰.原发性肝癌的非手术治疗[J].中国医药导报, 2013, 10 (14) :32-35.
    [21]YE SL.Loco-regional therapy for liver cancer[J].J Clin Hepatol, 2013, 29 (1) :28-31. (in Chinese) .叶胜龙.肝癌的局部区域治疗[J].临床肝胆病杂志, 2013, 29 (1) :28-31.
    [22]MOORE M, HIRTE H, SIU L, et al.Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors[J].Ann Oncol, 2005, 16 (10) :1688-1694.
    [23]VILLANUEVA A, NEWELL P, CHIANG DY, et al.Genomics and signaling pathways in hepatocellular carcinoma[J].Semin liver Dis, 2007, 27 (1) :55-76.
    [24]PARK W, LIM DH, PAIK SW, et al.Local radiotherapy for patients with unresectable hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys, 2005, 61 (4) :1143-1150.
    [25]LUO Z, RAO J, YIN WB.The status and current situation of radiotherapy in primary hepatocellular carcinoma[J].Chin J Radiat Oncol, 2006, 15 (4) :345-346. (in Chinese) 罗政, 饶建, 殷蔚伯.放疗在原发性肝癌治疗中地位和现状[J].中华放射肿瘤学杂志, 2006, 15 (4) :345-346.
    [26]BAI CM.Oncology principles and practice (9th edition) [J].Med J Peking Union Med Coll Hosp, 2012, 3 (3) :357. (in Chinese) 白春梅.癌:肿瘤学原理和实践 (第9版) [J].协和医学杂志, 2012, 3 (3) :357.
    [27]MORNEX F, GIRARD N, BEZIAT C, et al.Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma noneligible for curative therapies—mature results of the French Phase II RTF-1 trial[J].Int J Radiat Oncol Biol Phys, 2006, 66 (4) :1152-1158.
    [28]LIU MT, LI SH, CHU TC, et al.Three-dimensional Conformal Radiation Therapy for Unresectable Hepatocellular Carcinoma Patients who had Failed with or were Unsuited for Transcatheter Arterial Chemoembolization[J].Jpn J Clin Oncol, 2004, 34 (9) :532-539.
    [29]WU DH, LIU L, CHEN LH.Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma[J].World J Gastroenterol, 2004, 10 (15) :2184-2189.
    [30]LIANG SX, JIANG GL, ZHU XD, et al.Prognosis factor analysis of three-dimensional conformal radiotherapy in primary liver cancer[J].Chin J Oncol, 2005, 27 (10) :613-615. (in Chinese) 梁世雄, 蒋国梁, 朱小东, 等.原发性肝癌大分割三维适形放疗的预后因素分析[J].中华肿瘤杂志, 2005, 27 (10) :613-615.
    [31]JANG JW, KAY CS, YOU CR, et al.Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases[J].Int J Radiat Oncol Biol Phys, 2009, 74 (2) :412-418.
    [32]KANG MK, KIM MS, KIM SK, et al.High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma[J].Tumori, 2011, 97 (6) :724-731.
    [33]MENG MB, CUI YL, LU Y, et al.Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma:A systematic review and meta-analysis[J].Radiother Oncol, 2009, 92 (2) :184-194.
  • 加载中
计量
  • 文章访问数:  2866
  • HTML全文浏览量:  17
  • PDF下载量:  607
  • 被引次数: 0
出版历程
  • 出版日期:  2014-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回